Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.33 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3819236 | 0.90 | GRM5 (0.36) | GRM5LMNAMAPK1HTTTRPC3 | |
| SCHEMBL3813363 | 0.90 | TRPC3 (0.34) | GRM5LMNAMAPK1HTTTRPC3 | |
| SCHEMBL3817616 | 0.83 | HTT (0.40) | GRM5LMNAMAPK1HTTTRPC3 | |
| SCHEMBL3815429 | 0.83 | HTT (0.40) | GRM5LMNAMAPK1HTTTRPC3 | |
| SCHEMBL1872065 | 0.83 | GRM5 (0.53) | GRM5GAAKMT2AALDH1A1MAPT | |
| SCHEMBL3813334 | 0.82 | TRPC3 (0.44) | GRM5TRPC3TRPC6NPC1RAB9A | |
| SCHEMBL3816775 | 0.82 | TRPC3 (0.44) | GRM5TRPC3TRPC6NPC1RAB9A | |
| SCHEMBL3815639 | 0.82 | TRPC3 (0.44) | GRM5TRPC3TRPC6NPC1RAB9A | |
| SCHEMBL3813039 | 0.82 | HTT (0.41) | GRM5LMNAMAPK1HTTGAA | |
| SCHEMBL3813268 | 0.82 | GRM5 (0.35) | GRM5LMNAMAPK1HTTTRPC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | claimed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009095253-A1 | 6-HALO-PYRAZOLO[1, 5-A]PYRIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR (MGLUR) MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-08-06 | — | — | WO | disclosed |